Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes

Abstract Patients with cancer demonstrate particularly poor outcomes from COVID-19. To provide information essential for understanding the biologic underpinnings of this association, we analyzed whole-transcriptome RNA expression data obtained from a large cohort of cancer patients to characterize e...

Full description

Bibliographic Details
Main Authors: Andrew Elliott, Michelle Saul, Jia Zeng, John L. Marshall, Edward S. Kim, Misako Nagasaka, Heinz-Josef Lenz, Lee Schwartzberg, David Spetzler, Jim Abraham, Joanne Xiu, Phillip Stafford, W. Michael Korn
Format: Article
Language:English
Published: Nature Portfolio 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84731-7
_version_ 1830405139673907200
author Andrew Elliott
Michelle Saul
Jia Zeng
John L. Marshall
Edward S. Kim
Misako Nagasaka
Heinz-Josef Lenz
Lee Schwartzberg
David Spetzler
Jim Abraham
Joanne Xiu
Phillip Stafford
W. Michael Korn
author_facet Andrew Elliott
Michelle Saul
Jia Zeng
John L. Marshall
Edward S. Kim
Misako Nagasaka
Heinz-Josef Lenz
Lee Schwartzberg
David Spetzler
Jim Abraham
Joanne Xiu
Phillip Stafford
W. Michael Korn
author_sort Andrew Elliott
collection DOAJ
description Abstract Patients with cancer demonstrate particularly poor outcomes from COVID-19. To provide information essential for understanding the biologic underpinnings of this association, we analyzed whole-transcriptome RNA expression data obtained from a large cohort of cancer patients to characterize expression of ACE2, TMPRSS2, and other proteases that are involved in viral attachment to and entry into target cells. We find substantial variability of expression of these factors across tumor types and identify subpopulations expressing ACE2 at very high levels. In some tumor types, especially in gastrointestinal cancers, expression of ACE2 and TMPRSS2 is highly correlated. Furthermore, we found infiltration with T-cell and natural killer (NK) cell infiltration to be particularly pronounced in ACE2-high tumors. These findings suggest that subsets of cancer patients exist with gene expression profiles that may be associated with heightened susceptibility to SARS-CoV-2 infection, in whom malignant tumors function as viral reservoir and possibly promote the frequently detrimental hyper-immune response in patients infected with this virus.
first_indexed 2024-12-20T17:40:06Z
format Article
id doaj.art-de659d81a8a243fe8527f66b921f70ed
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-20T17:40:06Z
publishDate 2021-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-de659d81a8a243fe8527f66b921f70ed2022-12-21T19:31:08ZengNature PortfolioScientific Reports2045-23222021-03-011111810.1038/s41598-021-84731-7Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomesAndrew Elliott0Michelle Saul1Jia Zeng2John L. Marshall3Edward S. Kim4Misako Nagasaka5Heinz-Josef Lenz6Lee Schwartzberg7David Spetzler8Jim Abraham9Joanne Xiu10Phillip Stafford11W. Michael Korn12Caris Life SciencesCaris Life SciencesCaris Life SciencesRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical CenterLevine Cancer Institute, Atrium HealthDepartment of Oncology, Karmanos Cancer Institute, Wayne State UniversityUniversity of Southern California, Keck School of Medicine, Norris Comprehensive Cancer CenterMedical Oncology, West Cancer CenterCaris Life SciencesCaris Life SciencesCaris Life SciencesCaris Life SciencesCaris Life SciencesAbstract Patients with cancer demonstrate particularly poor outcomes from COVID-19. To provide information essential for understanding the biologic underpinnings of this association, we analyzed whole-transcriptome RNA expression data obtained from a large cohort of cancer patients to characterize expression of ACE2, TMPRSS2, and other proteases that are involved in viral attachment to and entry into target cells. We find substantial variability of expression of these factors across tumor types and identify subpopulations expressing ACE2 at very high levels. In some tumor types, especially in gastrointestinal cancers, expression of ACE2 and TMPRSS2 is highly correlated. Furthermore, we found infiltration with T-cell and natural killer (NK) cell infiltration to be particularly pronounced in ACE2-high tumors. These findings suggest that subsets of cancer patients exist with gene expression profiles that may be associated with heightened susceptibility to SARS-CoV-2 infection, in whom malignant tumors function as viral reservoir and possibly promote the frequently detrimental hyper-immune response in patients infected with this virus.https://doi.org/10.1038/s41598-021-84731-7
spellingShingle Andrew Elliott
Michelle Saul
Jia Zeng
John L. Marshall
Edward S. Kim
Misako Nagasaka
Heinz-Josef Lenz
Lee Schwartzberg
David Spetzler
Jim Abraham
Joanne Xiu
Phillip Stafford
W. Michael Korn
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
Scientific Reports
title Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
title_full Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
title_fullStr Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
title_full_unstemmed Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
title_short Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
title_sort pan cancer analysis of rna expression of angiotensin i converting enzyme 2 reveals high variability and possible impact on covid 19 clinical outcomes
url https://doi.org/10.1038/s41598-021-84731-7
work_keys_str_mv AT andrewelliott pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT michellesaul pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT jiazeng pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT johnlmarshall pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT edwardskim pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT misakonagasaka pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT heinzjoseflenz pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT leeschwartzberg pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT davidspetzler pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT jimabraham pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT joannexiu pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT phillipstafford pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes
AT wmichaelkorn pancanceranalysisofrnaexpressionofangiotensiniconvertingenzyme2revealshighvariabilityandpossibleimpactoncovid19clinicaloutcomes